Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PTHS compared with CNTB: revenue, margins and what each company keeps, and the suppliers and customers both name
PTHS
Pelthos Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
CNTB
Connect Biopharma Holdings Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
PTHS
Pelthos Therapeutics Inc.
vs
CNTB
Connect Biopharma Holdings Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
PTHS: latest quarter is a loss; flow not drawable. CNTB: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PTHS
19
—
Undisclosed wholesaler customer (35% of gross revenue)
unlisted
customer
—
Undisclosed wholesaler customer (35% of 2025 gross revenue)
unlisted
customer
—
Undisclosed wholesaler customer (28% of gross revenue)
unlisted
customer
—
Undisclosed wholesaler customer (28% of 2025 gross revenue)
unlisted
customer
15 more · PTHS chain
›
Shared
0
No disclosed counterparties: CNTB.
Only CNTB
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PTHS, solid
CNTB, dashed
PTHS
Pelthos Therapeutics Inc.
Change
9.91
▼
−2.36%
Mkt cap
$41.3M
Revenue
$16M
Q2 FY26
CNTB
Connect Biopharma Holdings Ltd
Change
0.73
▼
−6.23%
Regular session
Nov 5 '26
Mkt cap
$49.1M
Revenue
$3M
Q2 FY26
vs
Compare
Regular session
Nov 5 '26
PTHS
Pelthos Therapeutics Inc.
vs
CNTB
Connect Biopharma Holdings Ltd
9.91
▼
−2.36%
Price
0.73
▼
−6.23%
$41.3M
Mkt cap
$49.1M
Q2 FY26
$16M
Revenue
$3M
Q2 FY26
Change
Change
PTHS
9.91
▼
−2.36%
vs
CNTB
0.73
▼
−6.23%
Regular session
Nov 5 '26